FRI0127 IMPACT OF JANUS KINASE INHIBITORS ON RISK OF CARDIOVASCULAR EVENTS IN PATIENTS WITH RHEUMATOID ARTHRITIS: SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS

Cardiovascular Events ◽

Kinase Inhibitors ◽

Meta Analysis ◽

Janus Kinase ◽

Controlled Trials ◽

Janus Kinase Inhibitors ◽

Clinical efficacy and safety of Janus kinase inhibitors for COVID-19: A systematic review and meta-analysis of randomized controlled trials

International Immunopharmacology ◽

10.1016/j.intimp.2021.108027 ◽

2021 ◽

pp. 108027

Author(s):

Ching-Yi Chen ◽

Wang-Chun Chen ◽

Chi-Kuei Hsu ◽

Chien-Ming Chao ◽

Chih-Cheng Lai

Keyword(s):

Systematic Review ◽

Clinical Efficacy ◽

Kinase Inhibitors ◽

Meta Analysis ◽

Janus Kinase ◽

Controlled Trials ◽

Efficacy And Safety ◽

Janus Kinase Inhibitors ◽

Impact of Janus kinase inhibitors on the risk of cardiovascular events in patients with rheumatoid arthritis: systematic review and meta-analysis of randomised controlled trials

Annals of the Rheumatic Diseases ◽

10.1136/annrheumdis-2019-215815 ◽

2019 ◽

Vol 79 (10) ◽

pp. e122-e122 ◽

Cited By ~ 2

Author(s):

Young Ho Lee ◽

Gwan Gyu Song

Keyword(s):

Rheumatoid Arthritis ◽

Systematic Review ◽

Cardiovascular Events ◽

Randomised Controlled Trials ◽

Kinase Inhibitors ◽

Meta Analysis ◽

Janus Kinase ◽

Controlled Trials ◽

Janus Kinase Inhibitors ◽

Randomised Controlled

Response to: ‘Impact of Janus kinase inhibitors on the risk of cardiovascular events in patients with rheumatoid arthritis: systematic review and meta-analysis of randomised controlled trials’ by Lee and Song

Annals of the Rheumatic Diseases ◽

10.1136/annrheumdis-2019-215841 ◽

2019 ◽

Vol 79 (10) ◽

pp. e123-e123 ◽

Cited By ~ 1

Author(s):

Wenhui Xie ◽

Shiyu Xiao ◽

Zhuoli Zhang

Keyword(s):

Rheumatoid Arthritis ◽

Systematic Review ◽

Cardiovascular Events ◽

Randomised Controlled Trials ◽

Kinase Inhibitors ◽

Meta Analysis ◽

Janus Kinase ◽

Controlled Trials ◽

Janus Kinase Inhibitors ◽

Randomised Controlled

Janus kinase inhibitors for hospitalized patients with COVID-19: a meta-analysis of randomized controlled trials

Expert Review of Anti-infective Therapy ◽

10.1080/14787210.2022.2004120 ◽

2021 ◽

Author(s):

Shao-Huan Lan ◽

Chiung-Kai Wang ◽

Shen-Peng Chang ◽

Li-Chin Lu ◽

Shun-Hsing Hung ◽

...

Keyword(s):

Kinase Inhibitors ◽

Meta Analysis ◽

Hospitalized Patients ◽

Janus Kinase ◽

Controlled Trials ◽

Janus Kinase Inhibitors ◽

Janus kinase inhibitors for treating active ankylosing spondylitis: a meta-analysis of randomized controlled trials

Zeitschrift für Rheumatologie ◽

10.1007/s00393-020-00948-3 ◽

2020 ◽

Author(s):

Y. H. Lee ◽

G. G. Song

Keyword(s):

Ankylosing Spondylitis ◽

Kinase Inhibitors ◽

Meta Analysis ◽

Janus Kinase ◽

Controlled Trials ◽

Janus Kinase Inhibitors ◽

OP0032 Malignancies and serious infections in randomised controlled trials of janus kinase inhibitors in patients with rheumatoid arthritis: a systematic review and meta-analysis

10.1136/annrheumdis-2018-eular.7079 ◽

2018 ◽

Cited By ~ 2

Author(s):

M.A. Lopez-Olivo ◽

J.H. Tayar ◽

N.V. Zamora ◽

G. Pratt ◽

M.E. Suarez-Almazor

Keyword(s):

Rheumatoid Arthritis ◽

Systematic Review ◽

Randomised Controlled Trials ◽

Kinase Inhibitors ◽

Meta Analysis ◽

Janus Kinase ◽

Controlled Trials ◽

Janus Kinase Inhibitors ◽

Serious Infections ◽

Randomised Controlled

Janus kinase inhibitors and major COVID-19 outcomes: time to forget the two faces of Janus! A meta-analysis of randomized controlled trials

Clinical Rheumatology ◽

10.1007/s10067-021-05884-4 ◽

2021 ◽

Cited By ~ 2

Author(s):

Dimitrios Patoulias ◽

Michael Doumas ◽

Christodoulos Papadopoulos ◽

Asterios Karagiannis

Keyword(s):

Kinase Inhibitors ◽

Meta Analysis ◽

Janus Kinase ◽

Controlled Trials ◽

Janus Kinase Inhibitors ◽

The effectiveness and safety of Tripterygium wilfordii glycosides combined with disease‐modifying anti‐rheumatic drugs in the treatment of rheumatoid arthritis: A systematic review and meta‐analysis of 40 randomized controlled trials

Phytotherapy Research ◽

10.1002/ptr.6996 ◽

2020 ◽

Author(s):

Wenhao Zheng ◽

Yifan Mei ◽

Chunhui Chen ◽

Leyi Cai ◽

Hua Chen

Keyword(s):

Rheumatoid Arthritis ◽

Systematic Review ◽

Meta Analysis ◽

Controlled Trials ◽

Tripterygium Wilfordii ◽

Randomized Controlled ◽

Disease Modifying

Assessing the risk of angiotensin receptor blockers on major cardiovascular events: a systematic review and meta-analysis of randomized controlled trials

BMC Cardiovascular Disorders ◽

10.1186/s12872-020-01466-5 ◽

2020 ◽

Vol 20 (1) ◽

Author(s):

Yara Wanas ◽

Rim Bashir ◽

Nazmul Islam ◽

Luis Furuya-Kanamori

Keyword(s):

Systematic Review ◽

Cardiovascular Events ◽

Angiotensin Receptor Blockers ◽

Meta Analysis ◽

Controlled Trials ◽

Angiotensin Receptor ◽

Randomized Controlled ◽

Major Cardiovascular Events ◽

Receptor Blockers

The effects of renin–angiotensin system inhibitors on mortality, cardiovascular events, and renal events in hypertensive patients with diabetes: a systematic review and meta-analysis of randomized controlled trials

Hypertension Research ◽

10.1038/s41440-019-0234-6 ◽

2019 ◽

Vol 42 (5) ◽

pp. 669-680 ◽

Cited By ~ 3

Author(s):

Ayako Kunimura ◽

Nobuaki Himuro ◽

Akira Fujiyoshi ◽

Hiroyoshi Segawa ◽

Hirofumi Ohnishi ◽

...

Keyword(s):

Systematic Review ◽

Cardiovascular Events ◽

Meta Analysis ◽

Renin Angiotensin System ◽

Controlled Trials ◽

Angiotensin System ◽

Hypertensive Patients ◽

Randomized Controlled ◽

Patients With Diabetes